McGregor, TX, United States of America

Christie Sayes

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Baylor University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christie Sayes. Retrieved from https://idiyas.com/inventor/christie-sayes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Christie Sayes: Innovator in Medical Solutions

Introduction

Christie Sayes is a notable inventor based in McGregor, TX (US). He has made significant contributions to the field of medical solutions, holding a total of 3 patents. His work focuses on innovative treatments that address critical health conditions in mammals, including humans.

Latest Patents

One of Sayes' latest patents is an oxygen-enabled fluid, which is a colloid or crystalline solution enhanced with poly-oxygenated metal hydroxide particles. This solution is designed to treat conditions such as hemoglobin depletion and hemorrhagic shock in mammals. It can be administered intravenously, providing a vital therapeutic option. In some embodiments, the poly-oxygenated metal hydroxide used is an aluminum poly-oxygenated hydroxide, such as Ox66™. The particles in this solution have a diameter of less than or equal to 1 um, with specific sizes reaching less than or equal to 100 nm.

Another significant patent involves the administration of poly-oxygenated metal hydroxide to reduce the proliferation of carcinoma cells. This method also entails intravenously administering a therapeutically effective amount of the poly-oxygenated metal hydroxide, which may similarly be an aluminum poly-oxygenated hydroxide like Ox66™. The formulation typically consists of 75-90% colloid or crystalline solution, with an addition of 10-25% poly-oxygenated metal hydroxide particles.

Career Highlights

Christie Sayes is affiliated with Baylor University, where he continues to advance his research and innovations in medical treatments. His work has the potential to significantly impact the healthcare industry by providing new solutions for critical conditions.

Collaborations

Sayes collaborates with esteemed colleagues, including Erica D Bruce and John W Woodmansee, Jr. These partnerships enhance the research and development of his innovative medical solutions.

Conclusion

Christie Sayes exemplifies the spirit of innovation in the medical field, with his patents paving the way for new treatments that can save lives. His contributions are a testament to the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…